baclofen

Key facts

INN

baclofen

Brand

LIORESAL

Route

INTRATHECAL

Formulation

TABLET, ORALLY DISINTEGRATING

Originator

MAIA Biotechnology

Related patents

patent

US 12383522

Baclofen formulations and methods of minimizing patient exposure to metabolite v

Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12350245

Stable oral suspensions of baclofen

Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12295929

Intravenous baclofen formulations and treatment methods

Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12011502

Compositions and methods of administering baclofen

Expires Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11857524

Stable oral suspensions of baclofen

Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11850225

Baclofen formulations and methods of minimizing patient exposure to metabolite v

Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11523984

Compositions and methods of administering baclofen

Expires Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11491125

Baclofen formulations and methods of minimizing patient exposure to metabolite v

Expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is baclofen?

baclofen (LIORESAL), is a pharmaceutical active ingredient, associated with MAIA Biotechnology, with approved status in the US.

What is the brand name for baclofen?

LIORESAL is a marketed brand name for baclofen. Check FDA Drugs@FDA for the current US label holder.